{{'Search' | translate}}
 

Biosafety hood in a biosafety level 3 (BSL3)

生物安全级别3(BSL3)

Company: Hitachi
Catalog#: SCV-1303 ECIIB
Bio-protocol()
Company-protocol()
Other protocol()

Infection of Human Hepatocyte-chimeric Mice with HBV and in vivo Treatment with εRNA
Author:
Date:
2016-01-20
[Abstract]  Hepatitis B virus (HBV) can cause both acute and chronic disease in human liver with potentially high risk of cirrhosis and liver cancer. The host range of non-human primates susceptible to this virus is limited. Therefore, experimental studies with human hepatocyte-chimeric mice provide an invaluable source of information regarding the biology and pathogenesis of HBV. This section describes the protocol for infection of the human hepatocyte-chimeric mice with HBV. In addition, it has recently been shown that HBV replication can be suppressed by exogenous expression of viral epsilon RNA (εRNA; Sato et al., 2015), which serves as an encapsidation signal (Bartenschlager et al., 1992). Based upon this finding, we also describe the protocol for the liposome-mediated delivery ... [摘要]  乙型肝炎病毒(HBV)可引起人类肝脏的急性和慢性疾病,具有潜在的肝硬化和肝癌的高风险。 对这种病毒敏感的非人灵长类动物的宿主范围有限。 因此,用人肝细胞嵌合小鼠的实验研究提供了关于HBV的生物学和发病机理的非常宝贵的信息来源。 本节描述了用HBV感染人肝细胞嵌合小鼠的方案。 此外,最近已经表明,HBV复制可以通过作为壳体化信号的病毒ε-RNA(εRNA; Sato等人,2015)的外源表达来抑制(Bartenschlager et al。,1992)。 基于这一发现,我们还描述了脂质体介导的在这些嵌合小鼠中将编码εRNA的质粒递送至肝的方案。

Comments